We are live on ! Find out more

300 hedge funds and large institutions have $3.58B invested in ResMed in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 89 increasing their positions, 132 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $120M | Put options by funds: $73.1M

2.49% less ownership

Funds ownership: 54.51%52.02% (-2.5%)

4% less funds holding

Funds holding: 312300 (-12)

7% less capital invested

Capital invested by funds: $3.87B → $3.58B (-$288M)

24% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 37

33% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 132

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
300
Holders Change
-12
Holders Change %
-3.85%
% of All Funds
8.7%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
28
Increased
89
Reduced
132
Closed
37
Calls
$120M
Puts
$73.1M
Net Calls
+$46.9M
Net Calls Change
+$43.6M

RMD Hedge Fund Activity: Q3 2014 in Review

300 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2014, worth a combined $3.58B — down 7.4% from $3.87B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of RMD and 28 opened new positions — a net loss of 9 holders — while 132 trimmed existing stakes and 89 added.

The largest buyer was Invesco, adding an estimated $34.8M. The largest seller was Fidelity Investments, cutting an estimated $78.7M.

  • 300 institutional investors held ResMed (RMD) as of Q3 2014, down from 312 in Q2 2014.
  • Funds reported $3.58B of ResMed stock for Q3 2014, down 7.4% quarter-over-quarter.
  • 28 funds opened new ResMed positions in Q3 2014 and 37 closed out, a net change of -9 holders.
  • The largest ResMed buyer in Q3 2014 was Invesco, an estimated $34.8M added.
  • The largest ResMed seller in Q3 2014 was Fidelity Investments, an estimated $78.7M sold.

Based on aggregated 13F filings for Q3 2014.